DNA polymerase eta: A potential pharmacological target for cancer therapy - Saha - 2021 - Journal of Cellular Physiology - Wiley Online Library
Frontiers | Inhibiting DNA Polymerases as a Therapeutic Intervention against Cancer
DNA polymerases and cancer | Nature Reviews Cancer
PDB-101: Molecule of the Month: Cisplatin and DNA
Translesion polymerase kappa-dependent DNA synthesis underlies replication fork recovery | eLife
Molecules | Free Full-Text | Mammalian DNA Polymerase Kappa Activity and Specificity
Frontiers | DNA Damage Tolerance Pathways in Human Cells: A Potential Therapeutic Target
DNA polymerase eta: A potential pharmacological target for cancer therapy - Saha - 2021 - Journal of Cellular Physiology - Wiley Online Library
Switching off DNA repair—how colorectal cancer evades targeted therapies through adaptive mutability | Signal Transduction and Targeted Therapy
In vivo evidence that DNA polymerase kappa is responsible for error-free bypass across DNA cross-links induced by mitomycin C - ScienceDirect
Molecules | Free Full-Text | Mammalian DNA Polymerase Kappa Activity and Specificity
Regulation of the error-prone DNA polymerase Polκ by oncogenic signaling and its contribution to drug resistance | Science Signaling
DNA polymerase eta: A potential pharmacological target for cancer therapy - Saha - 2021 - Journal of Cellular Physiology - Wiley Online Library
Translesion Synthesis Polymerases in the Prevention and Promotion of Carcinogenesis
Unravelling roles of error-prone DNA polymerases in shaping cancer genomes | Oncogene
RCSB PDB - 6CST: Structure of human DNA polymerase kappa with DNA
Expression of the cancer-associated DNA polymerase ε P286R in fission yeast leads to translesion synthesis polymerase dependent hypermutation and defective DNA replication | PLOS Genetics
Translesion polymerase eta both facilitates DNA replication and promotes increased human genetic variation at common fragile sites | PNAS
Phosphorylation Alters the Properties of Pol η: Implications for Translesion Synthesis - ScienceDirect
Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy? | PLOS Genetics
-Western-Blot-H00051426-M01-img0015.jpg "DNA Polymerase Kappa Research Products: Novus Biologicals")